FTXH:NSD-First Trust Nasdaq Pharmaceuticals ETF

EQUITY | Others | NASDAQ Global Market

Last Closing

USD 20.59

Change

+0.02 (+0.10)%

Market Cap

USD 1.90M

Volume

1.70K

Analyst Target

N/A
Analyst Rating

N/A

ducovest Verdict

Verdict

About

The investment seeks investment results that correspond generally to the price and yield (before the fund's fees and expenses) of the Nasdaq US Smart Pharmaceuticals Index. The fund will normally invest at least 90% of its net assets (including investment borrowings) in common stocks that comprise the index. The index is designed to select pharmaceuticals stocks from the base index based on a ranking methodology of three price factors which aims to select companies that exhibit: strong growth through high average 3-, 6-, 9- and 12-month price return; value; and low expected volatility based on historical stock price fluctuation. It is non-diversified.

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2019-10-16 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
NVD GraniteShares 1.5x Short NVDA ..

+0.23 (+4.76%)

USD 1,052.59B
QQQM Invesco NASDAQ 100 ETF

+0.67 (+0.37%)

USD 22.08B
ACWI iShares MSCI ACWI ETF

+0.80 (+0.73%)

USD 19.51B
CGABL The Carlyle Group Inc. 4.625% ..

+0.01 (+0.05%)

USD 16.14B
CA Xtrackers California Municipal..

+0.01 (+0.04%)

USD 12.15B
JEPQ JPMorgan Nasdaq Equity Premium..

+0.14 (+0.26%)

USD 11.10B
GTR WisdomTree Target Range Fund

+0.11 (+0.47%)

USD 3.65B
TBIL Rbb Fund Inc - Us Treasury 3 M..

+0.02 (+0.04%)

USD 2.97B
IBTE iShares iBonds Dec 2024 Term T..

+0.01 (+0.04%)

USD 2.89B
TDI Touchstone Dynamic Internation..

+0.15 (+0.51%)

USD 2.81B

ETFs Containing FTXH

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange (NASDAQ Global Market)
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 7.18% 28% F 51% F
Dividend Return 0.34% 8% B- 4% F
Total Return 7.52% 24% F 48% F
Trailing 12 Months  
Capital Gain -9.56% 10% F 46% F
Dividend Return 0.45% 9% A- 4% F
Total Return -9.11% 9% A- 44% F
Trailing 5 Years  
Capital Gain N/A N/A N/A N/A F
Dividend Return N/A N/A N/A N/A F
Total Return N/A N/A N/A N/A F
Average Annual (5 Year Horizon)  
Capital Gain 2.22% 51% F 49% F
Dividend Return 3.20% 42% F 45% F
Total Return 0.98% 35% F 25% F
Risk Return Profile  
Volatility (Standard Deviation) 9.01% 60% D- 89% A-
Risk Adjusted Return 35.49% 40% F 56% F
Market Capitalization 1.90M 10% F 6% D-

Key Financial Ratios

  Ratio vs. Industry/Classification (Others) Ratio vs. Market (NASDAQ Global Market)
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
Market Value  
Price / Earning Ratio 27.20 24% 46%
Price/Book Ratio N/A N/A N/A
Price / Cash Flow Ratio N/A N/A N/A
Price/Free Cash Flow Ratio N/A N/A N/A
Management Effectiveness  
Return on Equity N/A N/A N/A
Return on Invested Capital N/A N/A N/A
Return on Assets N/A N/A N/A
Debt to Equity Ratio N/A N/A N/A

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:
Poor risk adjusted returns

This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.

Overpriced compared to earnings

The stock is trading high compared to its peers on a price to earning basis and is above the sector median.

Below median dividend returns

The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.

Below median total returns

The company has under performed its peers on annual average total returns in the past 5 years.

Low market capitalization

This is among the smaller entities in its sectors with below median market capitalization. That may make it less stable in the long run unless it has a unique technology or market which can help it grow or get acquired in future.